JENNIFER BRIGGS: Open Payments
NPI 1740246354 · CAVE CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,445 in 127 payments from 25 companies in 2025. Trend: 2023 $2,454 · 2024 $1,940 · 2025 $2,445
Food & beverage: $2,345Education: $100
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $322 |
| Insulet Corporation | 6 | $234 |
| ABBVIE INC. | 17 | $232 |
| GlaxoSmithKline, LLC. | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 3 | $207 |
| Amgen Inc. | 13 | $183 |
| Astellas Pharma US Inc | 5 | $150 |
| Novo Nordisk Inc | 12 | $147 |
| Axsome Therapeutics, Inc. | 5 | $89 |
| Corcept Therapeutics | 4 | $70 |
Products named: CAPLYTA, Omnipod, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, Wegovy, VRAYLAR, Auvelity.
Industry payments across KY — which companies pay providers there.
